Adam S. Grossman
2018
In 2018, Adam S. Grossman earned a total compensation of $1.6M as Director, President and Chief Executive Officer at ADMA Biologics, a 42% decrease compared to previous year.
Compensation breakdown
| Bonus | $215,205 |
|---|---|
| Option Awards | $728,537 |
| Salary | $536,000 |
| Other | $73,558 |
| Total | $1,553,300 |
Grossman received $728.5K in option awards, accounting for 47% of the total pay in 2018.
Grossman also received $215.2K in bonus, $536K in salary and $73.6K in other compensation.
Rankings
In 2018, Adam S. Grossman's compensation ranked 6,991st out of 14,244 executives tracked by ExecPay. In other words, Grossman earned more than 50.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 6,991 out of 14,244 | 51st |
Division Manufacturing | 2,683 out of 5,758 | 53rd |
Major group Chemicals And Allied Products | 1,009 out of 2,119 | 52nd |
Industry group Drugs | 848 out of 1,808 | 53rd |
Industry Biological Products, Except Diagnostic Substances | 163 out of 339 | 52nd |
Source: SEC filing on April 24, 2019.
Grossman's colleagues
We found two more compensation records of executives who worked with Adam S. Grossman at ADMA Biologics in 2018.
News
ADMA Biologics CEO Adam Grossman's 2023 pay jumps 128% to $6M
April 15, 2024
ADMA Biologics CEO Adam Grossman's 2022 pay falls 39% to $2.6M
April 13, 2023
ADMA Biologics CEO Adam Grossman's 2021 pay jumps 122% to $4.4M
April 28, 2022
ADMA Biologics CEO Adam Grossman's 2020 pay rises 15% to $2M
April 7, 2021
ADMA Biologics CEO Adam Grossman's 2019 pay rises 10% to $1.7M
April 29, 2020
ADMA Biologics CEO Adam Grossman's 2018 pay falls 42% to $1.6M
April 24, 2019